Suchergebnisse - "Festino, Lucia"

PubPharm (74)

1

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery : a multicenter, retrospective cohort study

enthalten in: EClinicalMedicine | 2024

von Bai, X. | Shaheen, A. | Grieco, C. | +43

ErratumFor: EClinicalMedicine. 2023 Oct 31;65:102290. - PMID 37965433

2

Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma

enthalten in: ResearchSquare.com | 2024

von Mallardo, D. | Sparano, F. | Vitale, M. | +13

3

Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Taylor, A. | McKeown, J. | Dimitriou, F. | +26

4

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery : a multicenter, retrospective cohort study

enthalten in: EClinicalMedicine | 2023

von Bai, X. | Shaheen, A. | Grieco, C. | +43

ErratumIn: EClinicalMedicine. 2024 Mar 27;71:102564. - PMID 38572079

5

Safety of extended interval dosing immune checkpoint inhibitors : a multicenter cohort study

enthalten in: Journal of the National Cancer Institute | 2023

von Cantini, L. | Paoloni, F. | Pecci, F. | +48

6

Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients

enthalten in: Journal of translational medicine | 2023

von Galati, D. | Zanotta, S. | Capone, M. | +11

7

Potential clinical implications of $ CD4^{+} %$ CD26^{high} $ T cells for nivolumab treated melanoma patients

enthalten in: Journal of translational medicine | 2023

von Galati, D. | Zanotta, S. | Capone, M. | +11

8

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Simeone, E. | Festino, L. | +18

9

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Simeone, E. | Festino, L. | +18

10

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Simeone, E. | Festino, L. | +18

1
2
3
4
5
6
7
8
Nächster »
[8]